← Leaderboards
Uwe Staerz
Greffex, Inc.
$11,247,049
Attributed
$11,247,049
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3M · FY2019–25$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,247,049 · 1
By mechanism
N01$11,247,049 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Advanced Development”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$378,174,673
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Joel A Lipkin · Four Points Technology, Llc$181,896,915
- Kimberly Smith · Ppd Development Lp$115,671,664
Research focus
Advanced DevelopmentCommunicable DiseasesContractsDisease OutbreaksEfficacy TestingFormulationImmunogenicityResponseStability TestingToxicologyVaccinesResearch Clinical TestingEventVaccine DevelopmentNonhuman PrimateInfluenza A VirusDoseInfluenza Virus VaccineEmerging Communicable DiseasesVaccine CandidateManufactureNational Institute Of Allergy And Infectious DiseasePhase I/Ii Clinical TrialAnimal Model
Grant awards (6)
Advanced Development of Vaccines for Influenza$416,330
N01 · FY2025 · AI · contact PI
Advanced Development of Vaccines for Influenza$1,256,003
N01 · FY2024 · AI · contact PI
Advanced Development of Vaccines for Influenza$1,280,042
N01 · FY2022 · AI · contact PI
Advanced Development of Vaccines for Influenza$2,543,566
N01 · FY2021 · AI · contact PI
Advanced Development of Vaccines for Infectious Diseases$2,955,109
N01 · FY2020 · AI · contact PI
Advanced Development of Vaccines for Infectious Diseases$2,795,999
N01 · FY2019 · AI · contact PI